Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

July 17, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Role of Inter-muscular adipose depots in Type2 Diabetes

The emergence of the Kappa variant of SARS-CoV-2

Liquid biopsy and droplet digital PCR help to detect Colorectal cancer

Role of Inter-muscular adipose depots in Type2 Diabetes
  • BiotechToday
  • World

Role of Inter-muscular adipose depots in Type2 Diabetes

BioTech Today July 12, 2021July 11, 2021

Akash Singh, Banaras Hindu University

Type 2 Diabetes (T2D), which affects over 20 million new cases annually, imposes an increased financial burden on healthcare systems worldwide in conjunction with the attributable high morbidity and mortality. The early identification of risk individuals and the swift implementation of primary and secondary preventative measures can however prevent most of this burden. Therefore it is essential to identify T2D-associated biomarkers to minimize the financial burden of morbidity, mortality, and healthcare due to this prevalent and chronic disease. To address this problem, the potential role of inter-muscular adipose deposits in pathophysiology for T2D by the use of biomarkers with CT has been recently published by a cohort study of 1,744 participants in the Multi-ethnic Atherosclerosis (MESA) study. This study aimed to examine the linkage between adipose tissue biomarkers derived from CT and normal glycemic adult T2D.

Cohort Study:

A cohort study is a type of panel study where the individuals in the panel share a common characteristic, in our case normoglycemia (baseline fasting plasma glucose [FPG] less than 100 mg/dL). From April 2010 and January 2012 to December 2017, this cohort of 1 744 participants from six U.S. communities was followed for an average of 7 years. The median age of the participants at baseline was 69±9 years and women were 977 (56.0%). Over an average of seven years, 103 participants (5.9%) were diagnosed with T2D and 147 (8.4%) died.

The inter-muscular adipose tissue (IMAT) and subcutaneous adipose tissue (SAT) areas were measured in baseline chest CT tests and corrected by height squares (SAT and IMAT indexes) using a predefined measuring protocol to investigate the associations between computed tomography (CT) derived adipose tissue biomarkers and T2D incidence in standard glucose adults. The main outcome of T2D was the follow-up to fasting glucose plasma (FPG), examination of hospital records, or self-reported medical diagnoses.

In this research, a link between the baseline IMAT and the follow-up incidence of T2D was observed. The potential role of adipose inter-muscle depots in T2D pathophysiology is suggested in this study and unmeasured residual confounders and one-time measurements of adipose tissue biomarkers were the limitations of this study.

Findings and Prospects:

The results of this research show that IMAT is associated with T2D incidence in chest CT tests (i.e. high IMAT index). The Inter-muscular adipose tissue (IMAT) index in chest CT tests may reflect overall deposition, which is linked to insulin resistance and possibly T2D (upper and lower bodies), of extra-myocellular adipose depots. IMAT is located close to muscle fibers and can act as an intermediary in insulin resistance by securing pro-inflammatory cytokines, extracellular matrix proteins, and increasing local fatty acids, and collectively altering the microenvironment of the skeleton. These results show that the IMAT index is still associated with T2D incidence when the effects of these clinical anthropometric indexes and IMAT are both accounted for in the model.

The IMAT deposition was associated with T2D incidence in normoglycemic participants. The potential role of adipose inter-muscle depots in T2D pathophysiology is suggested in this study. The adiposity biomarkers from CT tests performed for other initial evidence can be obtained and the value of the routine chest CT tests can be extended. The T2D incidence of this biomarker may be linked. This study can be the foundation of the protocols that are going to be created over the upcoming years to assess the risk of any disease by utilizing the biomarkers related to it.

Also read: How many tastes do you have?

Reference:

  1. Pishgar F, Shabani M, Quinaglia A. C. Silva T, Bluemke DA, Budoff M, Barr RG, et al. (2021) Adipose tissue biomarkers and type 2 diabetes incidence in normoglycemic participants in the MESArthritis Ancillary Study: A cohort study. PLoS Med 18(7): e1003700. https://doi.org/10.1371/journal.pmed.1003700

Author info:

Akash Singh is a first-year master’s student of Biochemistry at Banaras Hindu University. He plans to pursue Ph.D. in the future. He aims to research and teach the young minds of the country.

Social media links: LinkedIn: https://www.linkedin.com/in/akash-singh-82b5811a2/

Publications :

  1. https://bioxone.in/news/worldnews/a-potential-entry-point-in-autophagosomes-regulation/
  2. https://bioxone.in/news/worldnews/differentiation-pathways-in-human-treg-cells-revealed/
  3. https://bioxone.in/news/worldnews/multifunctional-microstructure-found-in-beetles-exoskeleton/
  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged adipose depots adipose tissue biomarkers cohort Diabetes IMAT Inter-muscular Inter-muscular adipose depots intermuscular normoglycemic SAT Subcutaneous T2D T2D-associated biomarkers Type2 Diabetes

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Liquid biopsy and droplet digital PCR help to detect Colorectal cancer

BioTech Today July 12, 2021

Shrestha Dutta, Amity University Kolkata What is Liquid biopsy? A fluid biopsy, otherwise called liquid biopsy or fluid phase biopsy, is the examination of non-solid organic tissue, principally blood. The fluid biopsy used in the investigation is known as rapid plasma genotyping – includes a test tube filled with blood, which contains DNA that is […]

Liquid biopsy

Related Post

  • BiotechToday
  • World

Cytokine GDF15 regulates a new energy metabolism pathway

BioTech Today October 20, 2021October 20, 2021

Arya Sukumar, College of Agriculture, Vellayani A novel pathway related to the activation of receptors associated with cardiovascular disorders like diabetes, obesity, and hypertension is described in research published in the journal Cell Reports. Many of the antidiabetic effects of PPAR β/δ receptor activators are controlled by cytokine GDF15. The research aids in the discovery […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Tocilizumab and Sarilumab receives WHO Approval for critically-ill Patients

BioTech Today July 9, 2021July 8, 2021

Agrima Bhatt, Rajasthan University Current Scenario The emergence of coronavirus from 2019 till now has led to a global healthcare crisis all over the world. Recent data of COVID-19 shows data as of July 7 having 184,324,026 confirmed cases and 3,992,680 deaths. Although vaccination has started to pick up pace in many countries, the risk […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Antifungal drug-delivery using micelles

bioxone August 18, 2021August 18, 2021

Saakshi Bangera, DY Patil School of Biotechnology and Bioinformatics Scientists at the University of South Australia have successfully engineered nanoparticles that are roughly the same size as a coronavirus particle. This innovation was done in partnership with Monash University. Nanobiotechnology is referred to as “micelles” and has an extraordinary ability to combat Candida Albicans – […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy